Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine have?
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine has 403 citations in the OpenAlex counts ScholarIQ stores.
When was Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine published?
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine has 2019 year in the ScholarIQ index.
What is the open-access status of Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine?
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine has bronze oa status in the ScholarIQ index.
What is the DOI of Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine?
The DOI for Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine is on the source record.
What is the PMID of Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine?
The PMID for Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine is on the source record.
What is the OpenAlex record for Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine?
The OpenAlex for Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine is on the source record.